BCC Research's latest report on single nucleotide polymorphism (SNP) technologies forecasts substantial growth from 2024 to 2029, highlighting key market trends, strategic insights, and the critical role of ESG factors in market dynamics and investor interest. BOSTON , Aug. 7, 2024 /PRNewswire/ -- According to the latest BCC Research study, the demand for " Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets " is expected to grow from $32.
0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.
The report comprehensively analyzes the SNP genotyping market segmented by technology and application, with detailed estimates and trends projected through 2029. The market is divided into four key regions: North America , Europe , Asia-Pacific , and the Rest of the World (RoW), each with unique characteristics and market dynamics. Using 2023 as the base year, the report includes forecasts from 2024 to 2029, offering a clear view of the expected market trajectory.
It employs analytical frameworks like PESTEL to assess external factors influencing the market, such as political, economic, social, technological, environmental, and legal aspects. The report also examines the competitive landscape, highlighting key players and their strategies, and explores emerging trends in ESG (Environmental, Social, and Governance) and funding, which are increasi.